Letters
Drug pricing scheme
European cooperation could help to lower drug prices
BMJ 2008; 337 doi: https://doi.org/10.1136/bmj.a1584 (Published 10 September 2008) Cite this as: BMJ 2008;337:a1584- Timothy D Heymann, reader in health management1
- 1Business School, Imperial College, London SW7 2AZ
- t.heymann{at}imperial.ac.uk
The National Institute for Health and Clinical Excellence (NICE) acknowledges that thought should be given not only to a drug’s effectiveness and quality adjusted life year (QALY) value but also to ways to influence the drug’s cost.1 But in …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.